Treatment with BBB022A or rolipram stabilizes the blood-brain barrier in experimental autoimmune encephalomyelitis: an additional mechanism for the therapeutic effect of type IV phosphodiesterase inhibitors
Autor: | Folcik, Virginia A a, Smith, Terence d, O'Bryant, Sage a, Kawczak, Julie A b, Zhu, Bin d, Sakurai, Hideki e, Kajiwara, Akiharu e, Staddon, James M d, Glabinski, Andrzej a, Chernosky, Ann L a, Tani, Marie a, Johnson, Justin M b, Tuohy, Vincent K b, c, Rubin, Lee L d, Ransohoff, Richard M a, c, * |
---|---|
Zdroj: | In Journal of Neuroimmunology 1999 97(1):119-128 |
Databáze: | ScienceDirect |
Externí odkaz: |